{
    "title": "Celltrion says Phase 1 trial shows COVID-19 antibody drug 'well-tolerated'",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8919899/Celltrion-says-Phase-1-trial-shows-COVID-19-antibody-drug-tolerated.html",
    "date": "2020-11-06",
    "keywords": [
        "ctp59",
        "celltrion",
        "covid19",
        "drug",
        "treatment",
        "antibody",
        "study",
        "phase",
        "trial",
        "company",
        "approval",
        "firm",
        "safety",
        "population",
        "recovery",
        "time",
        "placebo",
        "statement",
        "hospitalization",
        "therapy",
        "result",
        "month",
        "drugmaker",
        "emergency",
        "use",
        "end",
        "year",
        "research",
        "korea",
        "surface",
        "coronavirus",
        "production",
        "september",
        "anticipation",
        "demand",
        "kanishka",
        "singh",
        "bengaluru",
        "editing",
        "rashmi",
        "aich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}